The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $41.52

Today's change-2.04 -4.68%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $41.52

Today's change-2.04 -4.68%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA crosses below 200-day moving average

Fresenius Medical Care AG & Co KGaA closed sharply lower Friday, dropping (U.S.)$2.04 or 4.68% to (U.S.)$41.52 and crossing below its 200-day moving average. Shares have lost 6.68% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 20.04% during the last year.

Key company metrics

  • Open(U.S.) $42.56
  • Previous close(U.S.) $43.56
  • High(U.S.) $43.15
  • Low(U.S.) $41.43
  • Bid / Ask-- / --
  • YTD % change-0.76%
  • Volume564,028
  • Average volume (10-day)606,825
  • Average volume (1-month)302,611
  • Average volume (3-month)200,924
  • 52-week range(U.S.) $36.13 to (U.S.) $45.85
  • Beta0.61
  • Trailing P/E24.15×
  • P/E 1 year forward23.38×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.43
  • Dividend yield1.04%
  • Trailing EPS(U.S.) $1.72
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.91%

Based on its net profit margin of 7.91%, Fresenius Medical Care AG & Co KGaA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:Industry:

Latest Company News

    No News Results.

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue4,2314,1993,9604,320
Total other revenue--------
Total revenue4,2314,1993,9604,320
Gross profit1,3821,2971,1841,414
Total cost of revenue2,8502,9012,7762,906
Total operating expense3,6183,6523,4563,657
Selling / general / administrative770714655724
Research & development35343131
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-------1
Other operating expenses, total--------
Operating income614547504663
Interest income (expense), net non-operating-106-115-162-162
Gain (loss) on sale of assets--------
Other--------
Income before tax514445402546
Income after tax346310264403
Income tax, total168135138143
Net income262241210335
Total adjustments to net income--------
Net income before extra. items262241210335
Minority interest-83-69-55-67
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items262241210335
Inc. avail. to common incl. extra. items262241210335
Diluted net income262241210335
Dilution adjustment--0----
Diluted weighted average shares305305305304
Diluted EPS excluding extraordinary itemsvalue per share0.860.790.691.10
Dividends per sharevalue per share0.000.840.000.53
Diluted normalized EPSvalue per share0.860.790.691.10